"Turn Possibilities Into Growth"...Suwon's Innovation Platform PANN 9th Cohort
Suwon Special City held the "2026 Suwon Enterprise IR Day Suwon.PANN 9th Cohort" at the City Hall Conference Room on September 1st.
Eight companies selected through screening—OrganoPlus Co., Ltd., Reva Co., Ltd., Beyond DX Co., Ltd., Wellscare Co., Ltd., Zenix Cure Co., Ltd., YusBio Global Co., Ltd., IMD Pharma Co., Ltd., and H&S Biolab Co., Ltd.—presented their technologies and business initiatives to investment institutions and held investment consultations.
Eight investment institutions—IMM Investment, SBI Investment, GenAxis, Infobank iAccel, Daily Partners, KAIST Youth Startup Investment Holdings, Premier Partners, and POSCO Technology Investment—participated in investment consultations with the companies.
A city official stated, "Suwon Enterprise IR Day Suwon.PANN is Suwon's representative innovation platform that connects possibilities to actual growth," and added, "We hope that the companies taking the stage in the 9th cohort of Suwon.PANN will grow to become leaders driving South Korea's biotech industry."
Suwon Enterprise IR Day Suwon.PANN discovers small, venture, and startup companies in Suwon with excellent technological capabilities and growth potential, provides support to strengthen their IR capabilities, and offers opportunities to attract investment.
The 2026 Suwon Enterprise IR Day Suwon.PANN recruitment received applications from 202 companies. To provide opportunities to more companies, Suwon City selected a total of 32 companies (8 companies per cohort), an increase of 10 from the previous year.
Selected companies receive support including ▲one-on-one consulting for company diagnosis and investment attraction strategy development ▲IR storyline and speech capability enhancement consulting ▲IR pitching linked to investment review by investment management companies such as Suwon Enterprise Saebit Fund ▲networking with companies seeking investment and open innovation ▲recommendation and connection to Suwon City support programs ▲direct investment review by operators and recommendation and connection to support programs.